UBS Group
RMTI icon

UBS Group’s Rockwell Medical RMTI Stock Holding History

UBS Group’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-91
Closed -$23K – 8092
2018
Q4 		$23K Buy
+91
New +$36.2K ﹤0.01% 6672
2016
Q1 		– Sell
-1
Closed -$1K – 8079
2015
Q4 		$1K Hold
1
– – ﹤0.01% 8172
2015
Q3 		$1K Hold
1
– – ﹤0.01% 8233
2015
Q2 		$2K Sell
1
-11
-92% -$14K ﹤0.01% 8209
2015
Q1 		$14K Sell
12
-321
-96% -$376K ﹤0.01% 7355
2014
Q4 		$376K Buy
+333
New +$342K ﹤0.01% 4449

Other funds holding RMTI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group's RMTI Position: Q1 2026 in Review

UBS Group increased its Rockwell Medical (RMTI) stake by 28% in Q1 2026, buying an estimated $39K and bringing the position to 17,889 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #6761.

UBS Group first reported a position in RMTI in Q4 2014 and has held it in 46 quarters since. The position peaked at $556K in Q2 2016. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • UBS Group held 17,889 shares of Rockwell Medical worth $160K as of Q1 2026.
  • UBS Group bought 3,917 Rockwell Medical shares in Q1 2026, an estimated $39K.
  • Rockwell Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6761 holding.
  • UBS Group first reported a position in Rockwell Medical in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Rockwell Medical position peaked at $556K in Q2 2016.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.